Your search returned 2 results.

Results
	1.	Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial. MedStar authors: Aroda, Vanita R PMID: 31189519 Year: 2019 Citation: The Lancet Diabetes & Endocrinology. 7(8):596-605, 2019 08. Institution: MedStar Health Research Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Aroda VR, Gonzalez-Galvez G, Gron R, Halladin N, Haluzik M, Jermendy G, Kok A, Orsy P, Sabbah M, Sesti G, Silver R DOI: https://dx.doi.org/10.1016/S2213-8587(19)30184-6 Add to cart (remove)
	2.	A review of GLP-1 receptor agonists: Evolution and advancement, through the lens of randomised controlled trials. [Review] MedStar authors: Aroda, Vanita R PMID: 29364586 Year: 2018 Citation: Diabetes, Obesity & Metabolism. 20 Suppl 1:22-33, 2018 02. Institution: MedStar Health Research Institute Medline publication type: Journal Article Review Form of publication: Journal Article All authors: Aroda VR DOI: https://dx.doi.org/10.1111/dom.13162 Add to cart (remove)

Refine your search